Canada: Borden Ladner Gervais Offers A Biotech Outlook
Last Updated: June 19 2015

Toronto (June 16, 2015) — Borden Ladner Gervais (BLG) released the second edition of Life Signs, an instructive look at the life sciences legal trends shaping the Canadian industry at BIO2015.

The report arrives at a critical time — the convergence of scientific innovation, legislation, an aging demographic and investors looking for new opportunities. BLG's Life Signs reviews how the biotechnology sector in Canada will transform in the years to come.

BLG has a long history working with the life sciences community in Canada. The firm has one of Canada's leading life sciences practices with considerable experience in the protection of intellectual property, financing, commercialization, licensing, regulatory compliance, advocacy and dispute resolution.

Life Signs is a must read for anyone operating in the biotech space. Highlights include: 

  • An overview of the shifting ground of patentable subject matter in Canada
  • Regulatory trends that include recent amendments to the Food & Drugs Act and a regulatory framework for orphan drugs
  • Protecting biotech businesses against departing employees
  • Important new principles in contractual negotiations
  • The impact of precedent setting Supreme Court of Canada cases
  • A review of important changes to the Canadian Patent Practice

In addition to the observations made by BLG's biotechnology team, the report also includes the analysis of national and regional associations. Industry partners: BIOTECanada, Rx&D, BioNova, Life Sciences Ontario and Life Sciences BC all share their view into Canada's evolving biotech industry.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Jeffrey Graham, Ross McGowan, Stephen Redican, Prema Thiele, Robert Dawkins
By Manoj Pundit
By Bradley Freedman
By Scott Robson, Jonathan Doll, Manoj Pundit, Carol Derk, Ravi Latour, Melissa Smith
By Borden Ladner Gervais LLP
By Devin Persaud, Gregory McLean, Denes Rothschild
By Alan Ross, Stephanie Savoie
By Luke Dineley, Ramsey Glass
By Robert Dawkins, Ross McGowan
By Victoria Prince
Font Size: